<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-12T13:41:27Z</responseDate>
  <request identifier="oai:figshare.com:article/34023762" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34023762</identifier>
        <datestamp>2026-09-29T12:33:29Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_19</setSpec>
        <setSpec>category_24</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_45</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_62</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_63</setSpec>
        <setSpec>item_type_6</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Synthesis of the
pan-TEAD Inhibitor GDC-8025 via a
Flow Chan–Evans–Lam Coupling and Enantioselective Biocatalytic
α‑Ketoester Reduction</dc:title>
          <dc:creator>Nicholas A. White (4994780)</dc:creator>
          <dc:creator>Matthew M. Pompeo (23935680)</dc:creator>
          <dc:creator>Kyle Clagg (1695886)</dc:creator>
          <dc:creator>Jeff Shen (1520119)</dc:creator>
          <dc:creator>Di Xu (1443394)</dc:creator>
          <dc:creator>Carmela Molinaro (1685800)</dc:creator>
          <dc:creator>Lauren E. Sirois (2068171)</dc:creator>
          <dc:creator>Francis Gosselin (1442914)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Pharmacology</dc:subject>
          <dc:subject>Evolutionary Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Sociology</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Marine Biology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>sharpless asymmetric dihydroxylation</dc:subject>
          <dc:subject>reactive acrylamide warhead</dc:subject>
          <dc:subject>occupational toxicity concerns</dc:subject>
          <dc:subject>new route facilitated</dc:subject>
          <dc:subject>&gt;] pyridine core</dc:subject>
          <dc:subject>8 chemical steps</dc:subject>
          <dc:subject>generation route utilizing</dc:subject>
          <dc:subject>biocatalytic enantioselective reduction</dc:subject>
          <dc:subject>robust multikilogram synthesis</dc:subject>
          <dc:subject>7 &lt;/ b</dc:subject>
          <dc:subject>8025 &lt;/ b</dc:subject>
          <dc:subject>tead inhibitor gdc</dc:subject>
          <dc:subject>tead inhibitor</dc:subject>
          <dc:subject>8025 via</dc:subject>
          <dc:subject>h &lt;/</dc:subject>
          <dc:subject>b &lt;/</dc:subject>
          <dc:subject>nitrile reduction</dc:subject>
          <dc:subject>generation synthesis</dc:subject>
          <dc:subject>tandem ester</dc:subject>
          <dc:subject>requisite 4</dc:subject>
          <dc:subject>osmium tetroxide</dc:subject>
          <dc:subject>functionalized 1</dc:subject>
          <dc:subject>chemoselective acrylamidation</dc:subject>
          <dc:subject>&gt;- pyrazolo</dc:subject>
          <dc:subject>4 -&lt;</dc:subject>
          <dc:description>&lt;b&gt;GDC-8025&lt;/b&gt; is a potent
pan-TEAD inhibitor that features
a functionalized 1&lt;i&gt;H&lt;/i&gt;-pyrazolo[3,4-&lt;i&gt;b&lt;/i&gt;]pyridine core and a reactive acrylamide warhead. The first-generation
synthesis of &lt;b&gt;GDC-8025&lt;/b&gt; relied on a Sharpless asymmetric
dihydroxylation of &lt;b&gt;7&lt;/b&gt; to install the chiral diol moiety
(&lt;b&gt;8&lt;/b&gt;). This chemistry was not suitable for large scale
manufacturing due to the instability of the requisite 4-vinylpyridine
intermediate (&lt;b&gt;7&lt;/b&gt;) and occupational toxicity concerns of
osmium tetroxide. To address these challenges, a second-generation
route utilizing a biocatalytic enantioselective reduction of an α-ketoester
substrate (&lt;b&gt;18&lt;/b&gt;) was developed. Together with optimization
of a Chan–Evans–Lam coupling in flow, a tandem ester/nitrile
reduction, and a chemoselective acrylamidation, implementation of
this new route facilitated the robust multikilogram synthesis of &lt;b&gt;GDC-8025&lt;/b&gt; in 8 chemical steps.</dc:description>
          <dc:date>2026-09-29T00:00:00Z</dc:date>
          <dc:type>Text</dc:type>
          <dc:type>Journal contribution</dc:type>
          <dc:identifier>10.1021/acs.oprd.6c00216.s001</dc:identifier>
          <dc:relation>https://figshare.com/articles/journal_contribution/Synthesis_of_the_pan-TEAD_Inhibitor_GDC-8025_via_a_Flow_Chan_Evans_Lam_Coupling_and_Enantioselective_Biocatalytic_Ketoester_Reduction/34023762</dc:relation>
          <dc:rights>CC BY-NC 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
